molecular and multi modality imaging and theranostics of prostate cancer current state of the art
Published 3 years ago • 323 plays • Length 12:01Download video MP4
Download video MP3
Similar videos
-
11:53
future directions in molecular and multi modality imaging and theranostics of prostate cancer
-
9:58
molecular imaging for prostate cancer
-
12:41
psma: current state of the art and future vision
-
16:49
theranostics in prostate cancer
-
14:16
molecular imaging of prostate cancer
-
10:20
current clinical utility of mri and multi-modality imaging
-
10:50
urologic perspective on the current and emerging role of multi-modality imaging and radiogenomics
-
15:52
therapeutic radiopharmaceuticals and the emergence of theranostics in prostate cancer
-
11:02
integrated multi modality diagnostic evaluation of prostate cancer
-
16:19
incorporating new pet imaging and theranostic approaches into prostate cancer practice
-
10:35
integrating theranostics into a group practice
-
7:09
prostate theranostics and imaging centre of excellence
-
14:39
just the beginning: what's next for radiotheranostics in prostate cancer?
-
10:51
advanced prostate cancer clinical trials update 2022
-
6:18
updates of changes in the early detection of prostate cancer nccn guidelines 2021
-
7:40
koo - next generation imaging for prostate cancer
-
5:15
point-counterpoint: will conventional imaging become obsolete?–pro
-
5:52
future of imaging and theranostics in prostate cancer
-
28:33
active surveillance results and implications of prospective studies